Section of Cardiac Critical Care, Department of Pediatrics. University of Washington, Seattle, WA, USA.
Division of Critical Care Medicine - Cardiac Intensive Care, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Cardiol Young. 2023 Apr;33(4):532-538. doi: 10.1017/S1047951122001160. Epub 2022 May 4.
This multicenter study aimed to describe peri-intubation cardiac arrest in paediatric cardiac patients with significant (moderate or severe) systolic dysfunction of the systemic ventricle. Intubation data were collected from 4 paediatric cardiac ICUs in the United States (January 2015 - December 2017). Clinician practices during intubation of patients with significant dysfunction were compared to practices during intubation of patients without significant systolic dysfunction. There were 67 intubations in patients with significant systolic dysfunction. Peri-intubation cardiac arrest rate in this population was 14.9% (10/67); peri-intubation mortality was 3%. Majority (6/10; 60%) of the cardiac arrests were classified as pulseless electrical activity. Patients with cardiac arrest upon intubation had a higher serum lactate and lower serum pH than patients without peri-intubation cardiac arrest in the significant systolic dysfunction group.In comparing cardiac ICU patients with significant systolic dysfunction (n = 67) to patients from the same time period with normal ventricular function or mild dysfunction (n = 183), clinicians were less likely to use midazolam (11.9% versus 25.1%; p = 0.03) and more likely to use etomidate (16.4% versus 4.4%; p = 0.002) for intubation. Use of other sedative agents, video laryngoscopy, atropine, inotrope initiation, and consultation of an anaesthesiologist for intubation were not statistically different between the groups.This is the first study to describe the rate of and risk factors for peri-intubation cardiac arrest in paediatric cardiac ICU patients with systolic dysfunction. There was a higher peri-intubation cardiac arrest rate compared to published rates in critically ill children with heart disease and compared to children with significant systolic dysfunction undergoing elective general anaesthesia.
这项多中心研究旨在描述伴有严重(中度或重度)系统性心室收缩功能障碍的儿科心脏病患者的围插管期心脏骤停。从美国 4 家儿科心脏 ICU 收集了插管数据(2015 年 1 月至 2017 年 12 月)。比较了对有严重收缩功能障碍的患者进行插管时的临床医生实践与对无明显收缩功能障碍的患者进行插管时的实践。在伴有严重收缩功能障碍的患者中有 67 例发生围插管期心脏骤停。该人群围插管期心脏骤停发生率为 14.9%(10/67);围插管期死亡率为 3%。大多数(6/10;60%)心脏骤停被归类为无脉电活动。在伴有严重收缩功能障碍的患者中,发生心脏骤停的患者血清乳酸水平较高,血清 pH 值较低,而无围插管期心脏骤停的患者则较低。在比较伴有严重收缩功能障碍的心脏 ICU 患者(n=67)与同期心室功能正常或轻度障碍的患者(n=183)时,临床医生更倾向于使用咪达唑仑(11.9%比 25.1%;p=0.03),而更倾向于使用依托咪酯(16.4%比 4.4%;p=0.002)进行插管。在插管期间使用其他镇静剂、视频喉镜、阿托品、正性肌力药的起始使用以及咨询麻醉师的情况在两组之间无统计学差异。这是第一项描述伴有收缩功能障碍的儿科心脏病患者围插管期心脏骤停发生率和危险因素的研究。与患有心脏病的危重病儿童以及接受择期全身麻醉的严重收缩功能障碍儿童相比,围插管期心脏骤停发生率更高。